Q4 2023 · 13F-HR
Vivo Capital, LLCholdings as filed
Filed 2024-02-07 · accession 0001213900-24-010646
$1.22B
Reported value
47
Positions
2023-12-31
Period end
Holdings as filed
| CUSIP | Ticker | Issuer | Value | % port. | Shares | Class | Voting |
|---|---|---|---|---|---|---|---|
| 834203309 | SLNO | Soleno Therapeutics Inc | $338.8M | 27.7% | 8,418,093 | Common | SOLE |
| 38406L103 | — | Gracell Biotechnologies Inc | $95.8M | 7.85% | 9,546,485 | Common | SOLE |
| 925050106 | VRNA | Verona Pharma PLC | $84.5M | 6.92% | 4,249,918 | Common | SOLE |
| 413197104 | HRMY | Harmony Biosciences Holdings Inc | $84.2M | 6.89% | 2,606,247 | Common | SOLE |
| 00166B105 | ALXO | ALX Oncology Holdings Inc | $62.8M | 5.14% | 4,220,048 | Common | SOLE |
| 05337M104 | — | Avadel Pharmaceuticals PLC | $57.8M | 4.74% | 4,096,428 | Common | SOLE |
| 374163103 | GERN | Geron Corp | $50.9M | 4.17% | 24,143,681 | Common | SOLE |
| 880881107 | 430 | Terns Pharmaceuticals Inc | $43.2M | 3.54% | 6,657,992 | Common | SOLE |
| 92790C104 | VRDN | Viridian Therapeutics Inc | $36.6M | 2.99% | 1,678,207 | Common | SOLE |
| 87650L103 | TARS | Tarsus Pharmaceuticals Inc | $36.1M | 2.96% | 1,784,006 | Common | SOLE |
| 45114M109 | — | Icosavax, Inc. | $26.9M | 2.20% | 1,704,568 | Common | SOLE |
| 68062P106 | OLMA | Olema Pharmaceuticals Inc | $26.3M | 2.15% | 1,873,704 | Common | SOLE |
| 04635X102 | CATBUSD | Astria Therapeutics Inc | $19.1M | 1.56% | 2,482,727 | Common | SOLE |
| 02083G100 | NVLSEUR | Alpine Immune Sciences Inc | $15.6M | 1.28% | 819,275 | Common | SOLE |
| 89157D105 | TRML | Tourmaline Bio Inc. | $15.5M | 1.27% | 591,882 | Common | SOLE |
| 20451W101 | CMPS | Compass Pathway PLC | $14.1M | 1.15% | 1,608,000 | Common | SOLE |
| 26818M108 | DYN | Dyne Therapeutics Inc | $13.8M | 1.13% | 1,035,136 | Common | SOLE |
| 19240Q201 | COGT | Cogent Biosciences Inc | $13.2M | 1.08% | 2,244,941 | Common | SOLE |
| 92337C203 | VSTM | Verastem Inc | $12.5M | 1.03% | 1,538,461 | Common | SOLE |
| 22663K107 | CRNX | Crinetics Pharmaceuticals Inc | $12.5M | 1.02% | 350,000 | Common | SOLE |
| 449778109 | IOBTQ | IO Biotech Inc | $11.6M | 0.95% | 6,173,439 | Common | SOLE |
| 98887Q104 | ZLAB | Zai Lab Ltd | $11.3M | 0.92% | 411,677 | Common | SOLE |
| 03770N101 | APGE | Apogee Therapeutics Inc | $11.2M | 0.92% | 400,000 | Common | SOLE |
| 483497103 | KALV | KalVista Pharmaceuticals Inc. | $10.5M | 0.86% | 856,008 | Common | SOLE |
| 37186H209 | — | Genetron Holdings Ltd | $10.0M | 0.82% | 2,708,056 | Common | SOLE |
| 81749D107 | SERA | Sera Prognostics Inc | $9.9M | 0.81% | 1,650,440 | Common | SOLE |
| 805111101 | SVRA | Savara Inc | $9.8M | 0.80% | 2,088,323 | Common | SOLE |
| 82686Q101 | SLN | Silence Therapeutics PLC | $8.9M | 0.73% | 510,204 | Common | SOLE |
| 01671P100 | ALLKGUSD | Allakos Inc | $8.2M | 0.67% | 2,988,000 | Common | SOLE |
| N69605108 | PHVS | Pharvaris NV | $8.0M | 0.65% | 285,000 | Common | SOLE |
| 68622P109 | ORIC | Oric Pharmaceuticals Inc | $7.8M | 0.64% | 849,681 | Common | SOLE |
| 75525N107 | — | Rayzebio Inc | $6.9M | 0.56% | 110,581 | Common | SOLE |
| 29286M105 | — | Engene Holdings Inc. | $6.3M | 0.51% | 678,705 | Common | SOLE |
| 20454B104 | CMPX | Compass Therapeutics Inc | $5.5M | 0.45% | 3,556,023 | Common | SOLE |
| 462260100 | IOVA | Iovance Biotherapeutics Inc | $5.3M | 0.44% | 655,057 | Common | SOLE |
| 45783C200 | TIL | Instil Bio Inc | $4.8M | 0.39% | 624,340 | Common | SOLE |
| 04280A100 | ARWR | Arrowhead Pharmaceuticals Inc | $4.2M | 0.34% | 137,411 | Common | SOLE |
| 097702104 | BOLT1EUR | Bolt Therapeutics Inc | $3.9M | 0.32% | 3,521,291 | Common | SOLE |
| 24661P807 | DCTH | Delcath Systems, Inc. | $3.6M | 0.29% | 855,191 | Common | SOLE |
| 76200L309 | RZLT | Rezolute Inc | $3.2M | 0.26% | 3,242,842 | Common | SOLE |
| 90466Y103 | — | Unicycive Therapeutics | $3.0M | 0.25% | 3,470,152 | Common | SOLE |
| 23306J101 | — | DBV Technologies SA | $2.6M | 0.21% | 2,708,875 | Common | SOLE |
| 01626L105 | — | Aligos Therapeutics Inc | $2.4M | 0.19% | 3,547,030 | Common | SOLE |
| 192005106 | CDXS | Codexis, Inc | $1.2M | 0.10% | 388,144 | Common | SOLE |
| 00032Q104 | WHWK | Aadi Bioscience Inc | $1.0M | 0.08% | 509,572 | Common | SOLE |
| 438083107 | FIXXEUR | Homology Medicines, Inc. | $225,001 | 0.02% | 370,068 | Common | SOLE |
| 74019P108 | — | Precision Biosciences Inc | $51,193 | 0.00% | 140,255 | Common | SOLE |
Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.